Scientific work

Prof. Dr. Leylagül Kaynar

572 publications. The source of the information is stated next to each publication.

Back to profile

  1. Retrospective evaluation of patients with primary mediastinal large B-Cell lymphoma: Real life experience

    Annals of Medical Research, 2021

    DOI 10.5455/annalsmedres.2020.10.1026 Open-access full textSource: OpenAlex

  2. Poster: HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

    Clinical Lymphoma Myeloma & Leukemia, 2021

    DOI 10.1016/s2152-2650(21)01484-1 Source: OpenAlex

  3. İnvaziv Duktal Meme Karsinomu Tedavisi Sonrası Gelişen Akut Myeloid Lösemi

    LLM Dergi, 2021

    DOI 10.5578/llm.20219603 Source: OpenAlex

  4. Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

    Kocaeli Üniversitesi - AVESİS, 2021

    Source: OpenAlex

  5. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience

    Annals of Hematology, 2020

    DOI 10.1007/s00277-020-04077-4 PMID 32507911 17 citations (Europe PMC) Source: OpenAlex

  6. Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT – A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party

    Frontiers in Immunology, 2020

    DOI 10.3389/fimmu.2020.00586 PMID 32351502 20 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma

    Clinical Lymphoma Myeloma & Leukemia, 2020

    DOI 10.1016/j.clml.2020.02.017 PMID 32482539 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)

    Journal of clinical lipidology, 2020

    DOI 10.1016/j.jacl.2020.04.006 PMID 32423761 8 citations (Europe PMC) Source: OpenAlex

  9. A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity

    Clinical Lymphoma Myeloma & Leukemia, 2020

    DOI 10.1016/j.clml.2020.05.009 PMID 32605899 4 citations (Europe PMC) Source: OpenAlex

  10. The Outcome of Fungal Pneumonia with Hematological Cancer

    Infection and Chemotherapy, 2020

    DOI 10.3947/ic.2020.52.4.530 PMID 33377321 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  11. İmmün Yetmezlikli Hastalardan Elde Edilen Sitomegalovirüs İzolatlarındaki Gansiklovir Direncinin Araştırılması

    Mikrobiyoloji Bulteni, 2020

    DOI 10.5578/mb.70062 PMID 33107291 3 citations (Europe PMC) Source: OpenAlex

  12. Chemotherapy-induced Toxic Leukoencephalopathy

    Turkish Journal Of Neurology, 2020

    DOI 10.4274/tnd.2019.12369 Source: OpenAlex

  13. Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma

    Transfusion and Apheresis Science, 2020

    DOI 10.1016/j.transci.2020.102844 PMID 32586769 5 citations (Europe PMC) Source: OpenAlex

  14. Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura

    Hematology Transfusion and Cell Therapy, 2020

    DOI 10.1016/j.htct.2020.09.112 Source: OpenAlex

  15. Remisyon İndüksiyon Kemoterapisinde Posakonazol Proflaksisi Ne Zaman Başlanmalı

    DergiPark (Istanbul University), 2020

    Source: OpenAlex

  16. İyileştirme ve Geliştirme Süreci

    Turkiye Klinikleri Hematology - Special Topics, 2020

    Source: OpenAlex

  17. BRENTUXIMAB VEDOTIN CONSOLIDATION THERAPY AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK HODGKIN’xxS LYMPHOMA: MULTI-CENTER REAL-LIFE EXPERIENCE

    AYBU AVESIS, 2020

    Source: OpenAlex

  18. Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)

    Journal of clinical lipidology, 2019

    DOI 10.1016/j.jacl.2019.02.001 PMID 30928440 33 citations (Europe PMC) Source: OpenAlex

  19. Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation – a prospective, non-interventional study of the EBMT Transplant Complication Working Party

    Haematologica, 2019

    DOI 10.3324/haematol.2019.228668 PMID 31601686 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  20. Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience

    Annals of Hematology, 2019

    DOI 10.1007/s00277-019-03899-1 PMID 31844933 6 citations (Europe PMC) Source: OpenAlex

  21. Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable ≥Vgpr Responses Among Immunomodulatory / Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey

    Clinical Lymphoma Myeloma & Leukemia, 2019

    DOI 10.1016/j.clml.2019.09.402 2 citations (OpenAlex) Source: OpenAlex

  22. Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study

    Turkish Journal of Hematology, 2019

    DOI 10.4274/tjh.galenos.2019.2019.0008 PMID 31131598 Open-access full textSource: OpenAlex

  23. The Importance of CMV PCR Monitoring in Hematologic Malignant Patients Take Chemotherapy

    LLM Dergi, 2019

    DOI 10.5578/llm.68984 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  24. PS1245 NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: LONG TERM RESULTS OF MULTI‐CENTER EXPERIENCE IN TURKEY

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000563260.18006.d6 Open-access full textSource: OpenAlex

  25. PB1688 SUCCESSFUL HAPLOIDENTIC BONE MARROW TRANSPLANTATION WITH INOTUZUMAB OZOGAMICIN IN PATIENT WITH RELAPSED AND RESISTANT B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000565268.92117.90 Open-access full textSource: OpenAlex

  26. Herediter anjioödemde kısa dönem danazol profilaksisi ile implant tedavisi: Vaka raporu

    Selcuk Dental Journal, 2019

    DOI 10.15311/selcukdentj.384245 Source: OpenAlex

  27. Kronik Graft Versus Host Hastalığı: Kurtarma Tedavileri

    Turkiye Klinikleri Hematology - Special Topics, 2019

    Source: OpenAlex

  28. Kronik Graft Versus Host Hastalığı

    2019

    Source: OpenAlex

  29. Gastrointestinal plasmoblastic lymphoma associated with Wiskott-Aldrich syndrome: a case report

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30311-x Source: OpenAlex

  30. Successful treatment of relapsed and refractory cold agglutinin disease with bortezomib: case report

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30375-3 Source: OpenAlex

  31. Risk factors for invasive fungal infection in patients who underwent allogeneic hematopoietic stem cell transplantation

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30351-0 Source: OpenAlex

  32. Evaluation of secondary hypogammaglobulinemia in patients with hematologic malignancy receiving ibrutinib therapy

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30293-0 Source: OpenAlex

  33. Gastrointestinal Plasmoblastic Lymphoma Associated with Wiskott-Aldrich Syndrome: A Case Report

    Blood, 2019

    DOI 10.1182/blood-2019-123387 Source: OpenAlex

  34. Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data

    Blood, 2019

    DOI 10.1182/blood-2019-126006 Source: OpenAlex

  35. Chronic Graft Versus Host Disease

    2019

    Source: OpenAlex

  36. Nivolumab for relapsed or refractory Hodgkin lymphoma: long term results of multi-center experience in Turkey

    AYBU AVESIS, 2019

    Source: OpenAlex

  37. Relaps/Refrakter Hodgkin Lenfomada Nivolumab: Çok Merkezli Türkiye Deneyimi Uzun Dönem Sonuçları

    AYBU AVESIS, 2019

    Source: OpenAlex

  38. Cytokine release syndrome

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2018.09.002 Source: OpenAlex

  39. Infection control bundles in intensive care: an international cross-sectional survey in low- and middle-income countries

    Journal of Hospital Infection, 2018

    DOI 10.1016/j.jhin.2018.07.022 PMID 30036635 19 citations (Europe PMC) Source: OpenAlex

  40. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)

    Atherosclerosis, 2018

    DOI 10.1016/j.atherosclerosis.2018.01.034 PMID 29407887 32 citations (Europe PMC) Source: OpenAlex

  41. Outcomes for haematological cancer patients admitted to an intensive care unit in a university hospital

    Australian Critical Care, 2018

    DOI 10.1016/j.aucc.2017.10.005 PMID 29429570 13 citations (Europe PMC) Source: OpenAlex

  42. Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up

    Hematology, 2018

    DOI 10.1080/10245332.2018.1498167 PMID 29996726 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  43. A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study

    Transfusion and Apheresis Science, 2018

    DOI 10.1016/j.transci.2018.02.012 PMID 29503132 7 citations (Europe PMC) Source: OpenAlex

  44. Severe Herpes Zoster Ophtalmicus in an Immuncompromised Patients

    Journal of Clinical Practice and Research, 2018

    DOI 10.5152/etd.2017.0118 Source: OpenAlex

  45. Response to the Letter to the Editor: Critically ill Haematological Cancer Patients: How far the Severity Index Score can determine the outcome and duration of Aggressive Support?

    Australian Critical Care, 2018

    DOI 10.1016/j.aucc.2018.07.002 PMID 30415912 Source: OpenAlex

  46. The Comparison of Melphalan Administration on Day −3 With Administration on Day −1 on Neutrophil and Platelet Engraftment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

    Journal of Global Oncology, 2018

    DOI 10.1200/jgo.18.88300 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  47. The Comparison of Melphalan Administration on Day 3 with Administration on Day 1 on Neutrophil and Platelet Engraftment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

    Blood, 2018

    DOI 10.1182/blood-2018-99-115353 1 citation (OpenAlex) Source: OpenAlex

  48. Hiperlipidemi Tedavisinde Terapötik Aferez

    Turkiye Klinikleri Endocrinology - Special Topics, 2018

    Source: OpenAlex

  49. Severe Herpes Zoster Ophtalmicus in an Immuncompromised Patient

    Journal of Clinical Practice and Research, 2018

    DOI 10.5152/etd.2018.18118 Source: OpenAlex

  50. Successful Treatment With Granulocyte Transfusion and Early Neutrophil Engraftment in Allogeneic Transplant Patients With Febrile Neutropenia: Does Granulocyte Transfusion Effect on Neutrophil Engraftment?

    Journal of Global Oncology, 2018

    DOI 10.1200/jgo.18.91100 Open-access full textSource: OpenAlex